Development of monoclonal antibody-mediated interventions to combat malaria

NIH RePORTER · NIH · N43 · $299,777 · view on reporter.nih.gov ↗

Abstract

This contract is to provide proof of concept studies for the development of a vector-based delivery of a potent P. falciparum-neutralizing monoclonal antibody.

Key facts

NIH application ID
10712191
Project number
75N93022C00021-0-9999-1
Recipient
CURE SYSTEMS LLC
Principal Investigator
JACQUELINE MILLER
Activity code
N43
Funding institute
NIH
Fiscal year
2022
Award amount
$299,777
Award type
Project period
2022-08-26 → —